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Noroviruses cause most cases of acute viral gastroenteritis worldwide. The lack of a cell
culture infection model for human norovirus necessitates the use of molecular methods
and/or viral surrogate models amenable to cell culture to predict norovirus inactivation.
Murine norovirus (MNV) may be used to construct a small animal model for studying the
biology and pathogenesis of noroviruses because MNV is the only norovirus that replicates
in cell culture and a small animal model. However, recent studies have shown that natural
MNV infection is widespread in laboratory mouse colonies.We investigated MNV infection
in both conventional and speciﬁc pathogen-free (SPF) genetically modiﬁedmice from Japan
and the US, and commercial mice from several animal breeders in Japan, using serological
and molecular techniques. MNV antibodies were detected in 67.3% of conventional mice
and 39.1% of SPF mice from Japan and 62.5% of conventional mice from the US. MNV
antibodies were also found in 20% of commercial SPF C57BL/6 mice from one of three
breeders. Partial gene ampliﬁcation of fecal isolates from infected animals showed that the
isolates were homologous to reported MNV sequences. These results suggest that both
conventional and SPF laboratory mice, including commercial mice, are widely infected with
MNV, which might require considerable attention as an animal model of human disease.
Keywords: genetically modified mice, mice, microbiological monitoring, MNV, mouse norovirus, specific
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INTRODUCTION
Human noroviruses are themajor cause of non-bacterial epidemic
gastroenteritis worldwide (Patel et al., 2009). The study of human
norovirus has been hampered by the lack of a cell culture system.
Murine norovirus (MNV) was ﬁrst isolated and characterized as a
sporadic and lethal pathogen in immunocompromised knockout
mice (Karst et al., 2003). MNV is the only norovirus that replicates
in cell culture and in a small animal model, though several studies
have reported norovirus infection in humans, cattle, swine, dogs,
and mice (Wobus et al., 2006; Patel et al., 2009). Thus, MNV is
expected to be a surrogate for evaluating the resistance of human
norovirus to disinfectants and can be used in animalmodel studies
of human norovirus infection.
Natural MNV infection is prevalent in animal facilities around
the world (Hsu et al., 2005; Perdue et al., 2007; Pritchett-Corning
et al., 2009). These infections might inﬂuence not only the results
of a mouse model for studying the biology and pathogenesis of
noroviruses, but also those of other biological studies (Lencioni
et al., 2008; Cadwell et al., 2010). Until recently, no MNV infec-
tion had been reported in laboratory mice in Japan. However, the
ﬁrst reports of MNV detected in conventional mouse colonies in
Japan were published in 2009 (Goto et al., 2009b; Kitajima et al.,
2009). Recent serological analysis of MNV found thatMNV infec-
tion is also prevalent in conventional animal colonies in Japan
(Kitagawa et al., 2010). However, information on the prevalence
of MNV infection in speciﬁc pathogen-free (SPF) mice colonies
and commercial SPFmice in Japan is not currently available. Most
researchers in Japan think that MNV infection is absent among
SPF mice facilities.
The Institute of Resource Development and Analysis at
Kumamoto University collects, preserves, and distributes exper-
imental animals; thus, numerous mice are transferred to the insti-
tute from across Japan and from the other countries for embryo
freezing or microbiological cleaning (Nakagata and Yamamura,
2009). Our division in the institute checks themicrobiological sta-
tus of geneticallymodiﬁedmice before or after embryo transfer. In
the present study, we examined the prevalence of MNV infection
in conventional and SPF genetically modiﬁed mice and commer-
cial SPF mice using both serological and molecular biological
methods.
MATERIALS AND METHODS
MICE
Ninety-six genetically modiﬁed mice derived from 29 facilities in
2011, including 18 mice derived from ﬁve different animal facil-
ities in the US which were to be converted to SPF grade by in
vitro fertilization, were used in this study. Thirty commercial SPF
C57BL/6 mice derived from three breeders in Japan were tested
for MNV infection. After arriving at our facility, the mice were
kept in the laminar ﬂow racks (negative air pressure) in our quar-
antine animal rooms, which are separate from the SPF animal
rooms, until the collection of embryos and sperm. The quar-
antine period was less than 1 week, except for ﬁve mice used
in an experiment for the frequency of detection of MNV. All
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procedures involving animals and their care were approved by
the Animal Care Committee of Kumamoto University in accor-
dance with the Regulations for Animal Experiments at Kumamoto
University.
MICROBIOLOGICAL MONITORING
The animals were checked for the presence of speciﬁc pathogens
using routine methods described previously (Goto et al., 2009a).
Brieﬂy, the analysis included a range of viruses, bacteria,mycoplas-
mas, and protozoans, which are listed in full in Table 1. The
absence of all tested pathogens indicated that an animal was SPF
grade.
SEROLOGICAL TEST FOR MNV
Serological analysis of MNV infection was performed using
an enzyme-linked immunosorbent assay (ELISA) kit (Mouse
Norovirus; Biotech Trading Partners, Encinitas, CA,USA) accord-
ing to the manufacturer’s protocol.
RNA ISOLATION AND REVERSE TRANSCRIPTASE-POLYMERASE CHAIN
REACTION
Total RNA was extracted from fresh feces as described
previously (Nakamura et al., 2005). Primers and reverse
transcriptase-polymerase chain reaction (RT-PCR) conditions
were described elsewhere (Kitajima et al., 2009). PCR products
were separated by 2% agarose gel electrophoresis.
SEQUENCE ANALYSIS
Polymerase chain reaction products were sequenced as described
previously (Ohsugi et al., 2004). Nucleotide sequences were
aligned using ClustalW. A phylogenetic tree was generated from a
bootstrap analysis of 1,000 replicates using the neighbor joining
method. Evolutionary distances were computed by the p-distance
method using MEGA 5.05 software (Tamura et al., 2011).
RESULTS
IDENTIFICATION OF MICROBIOLOGICAL STATUS IN MICE REARED
UNDER SPF OR CONVENTIONAL CONDITIONS
Microbiological analysis was performed in 96mice from29 animal
facilities, including 18 mice from ﬁve US facilities. In addition, 10
of each SPF female C57BL/6 mouse were purchased from breed-
ers A, B, and C (Figure 1). Most of the tested mice were negative
for viruses and bacteria (Table 1). Mycoplasma pulmonis was iso-
lated from a single mouse from a Japanese conventional facility.
Trichomonas spp. contamination was common in US facilities,
Table 1 | Microbiological status in tested facilities.
Pathogens Methods* U.S. facilities Domestic facilities Breeders
SPF† Conv† SPF Conv A B C
Viruses
Mouse hepatitis virus E, I 0/2‡ 0/16 0/23 0/55 0/10 0/10 0/10
Sendai virus E, I 0/2 0/16 0/23 0/55 0/10 0/10 0/10
Bacteria and mycoplasma
Citrobacter rodentium C 0/2 0/16 0/23 0/55 0/10 0/10 0/10
Clostridium piliforme E, I 0/2 0/16 0/23 0/55 0/10 0/10 0/10
Corynebacterium C 0/2 0/16 0/23 0/55 0/10 0/10 0/10
Helicobacter hepaticus RT-PCR 0/2 0/16 0/23 0/55 0/10 0/10 0/10
Mycoplasma pulmonis C, E, I 0/2 0/16 0/23 1/55 0/10 0/10 0/10
Pasteurella C 0/2 0/16 0/23 0/55 0/10 0/10 0/10
Salmonella spp. C 0/2 0/16 0/23 0/55 0/10 0/10 0/10
Parasites and protozoa
Aspiculuris tetraptera M 0/2 0/16 0/23 23/55 0/10 0/10 0/10
Syphacia spp. M 0/2 0/16 0/23 6/55 0/10 0/10 0/10
Giardia muris M 0/2 0/16 0/23 0/55 0/10 0/10 0/10
Spironucleus muris M 0/2 0/16 0/23 0/55 0/10 0/10 0/10
Trichomonas spp. M 0/2 16/16 0/23 12/55 0/10 0/10 0/10
Octomitus pulcher M 0/2 0/16 0/23 1/55 0/10 0/10 0/10
Entamoeba spp. M 0/2 0/16 0/23 6/55 0/10 0/10 0/10
Chilomastix spp. M 0/2 0/16 0/23 3/55 0/10 0/10 0/10
Ectoparasite M 0/2 0/16 0/23 5/55 0/10 0/10 0/10
*C, culture; E, ELISA; I, indirect ﬂuorescent antibody method; M, microscopic examination; RT-PCR, reverse transcriptase-polymerase chain reaction.
†SPF, speciﬁc pathogen-free; Conv, conventional.
‡Number of positive/number of tested. Positive results are indicated in bold.
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FIGURE 1 | Numbers of tested mice.Two SPF and 16 conventional mice
derived from US animal facilities, 23 SPF and 55 conventional mice derived
from domestic facilities, and 10 of each SPF female C57BL/6 mouse
obtained from breeders A, B, and C were tested in this study.
despite their disparate geographic locations across the country.
Almost all of the mice reared under conventional conditions were
positive for parasites and protozoa.
ANTIBODIES TO MNV IN ANIMAL FACILITIES IN JAPAN AND THE US
AND COMMERCIAL MICE IN JAPAN
Speciﬁc pathogen-free mice from the US were negative for MNV,
whereas 62.5% (10/16) of conventionalmice fromUS animal facil-
ities were positive for MNV (Figure 2A). MNV infection was
found in 39.1% (9/23) of SPF and 67.3% (37/55) of conventional
mice in Japan. Surprisingly, antibodies were found in 20% (2/10)
of commercial SPF mice derived from breeder C.
DETECTION OF MNV IN FECES FROM SPF OR CONVENTIONAL MICE
Stool specimens were collected from 126 animals from 32 sep-
arate laboratory colonies in Japan and the US and screened for
MNV (Figure 2B). NoMNV genome segments were isolated from
SPF mice from the US, similar to the serological study, whereas
MNV was isolated from 25% (4/16) of conventional mice. MNV
was isolated from 26% (6/23) of SPF mice and 27.3% (15/55)
of conventional mice from Japan. The frequency of MNV isola-
tion was similar between SPF and conventional mice from Japan
and the US. In commercial SPF mice, MNV was isolated from
20% (2/10) of the mice from breeder C. The mice positive by
both serological and molecular biological methods are shown in
Figure 2C. These results suggest thatMNV infection is widespread
in both conventional and SPFmice, including commercial mice in
Japan.
FREQUENCY OF DETECTION OF MNV
Five mice were autopsied 4 weeks after MNV-speciﬁc sequence
detection and tested for antibodies against MNV (Table 2). All
tested mice had antibodies for MNV. The MNV-speciﬁc sequence
was not always detected in the feces of the mice except mice D
FIGURE 2 | Prevalence of MNV infection in conventional and SPF mice.
(A) MNV seropositive mice from animal facilities in Japan and the US and
breeders in Japan. (B) RT-PCR detection of MNV sequences in feces from
tested mice. (C) Mice positive for both MNV antibodies by ELISA and
MNV-speciﬁc sequences in feces by RT-PCR. SPF, speciﬁc pathogen-free;
Conv, conventional.
and E during tested 4 weeks. The sensitivity of RT-PCR did not
improve with different PCR conditions, PCR reagents, or primers.
Thus, we speculated that the amount of MNV particles in the feces
might vary in each mouse due to, for example, host defenses or
intestinal circumstances.
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Table 2 | Change of MNV detection from feces after the first
isolation.
Mice Week after detection of MNV ELISA
0 1 2 3 4
A +* + − − − +
B + − − + − +
C + − − − − +
D + + + + + +
E + + + + + +
*RT-PCR positive.
PHYLOGENETIC ANALYSIS
The partial nucleotide sequence was determined for the 5′ ter-
minus of the capsid gene (Figure 3). Phylogenetic analysis of
the partial capsid sequences of MNV showed widespread expres-
sion in various facilities throughout Japan and the US, and that
these virus strains comprise reported MNV subgroups. Reference
strainsMNV-1 andKu29derived fromanSPF facility in Japanwere
divergent from the other strain group including reference stains
MNV-2, -3, and -4. Ku02 andKu04 derived from the same facilities
in Japan exhibited moderate similarity, but the sequences of Ku22
and Ku23 derived from different conventional US facilities were
closely related despite their disparate geographic locations across
the country.
DISCUSSION
In this study, we analyzed MNV infection in mice derived from
animal facilities in Japan, the US, and three breeders (Japan)
using serological and molecular techniques. We show that MNV
infection is widespread among both conventional and SPF mice
in Japan, as well as commercial SPF mice. In a previous study,
serological analysis revealed that 53.4% of conventional mice are
positive for MNV, 48% positive for mouse hepatitis virus, and
31.2% positive for M. pulmonis (Kitagawa et al., 2010). Consis-
tent with this report, we show that MNV is the most prevalent
infection in mouse laboratory colonies, and the mice we tested,
with the exception of one case, were negative for the antibodies
for hepatitis virus and M. pulmonis (Table 1). This report is
FIGURE 3 | Phylogenetic analysis of the partial capsid gene of
norovirus (approximately 350 nucleotides). Phylogenetic relationships
were inferred using the neighbor joining method, with the evolutionary
distances computed using the p-distance model. The statistical support
for tree nodes was evaluated by bootstrap analysis (1,000 replicates).
Bootstrap values (>50%) are indicated at branch nodes. Scale bar
indicates nucleotide substitutions per site. Numbers in parentheses indicate
GenBank accession numbers. Human isolates, Norwalk, Alphatron, Bristol,
and Hawaii; bovine isolate, Jena; North American isolates, MNV-1, -2, -3, and
-4, GV/NIH-4428/2005/USA, Ku22, and Ku 23; European isolate, Berlin;
Japanese isolates, S7-P2, S7-PP3, MNV/M1/JP, MT30-2, Ku02, Ku04, Ku46,
and Ku29 (SPF mice).
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the ﬁrst on MNV infection in SPF mice in Japan and commer-
cial mice.
The frequency of MNV infection as detected by RT-PCR was
lower than that detected by serological study using ELISA. We
detected MNV antibodies in all ﬁve mice tested 4 weeks after the
ﬁrst MNV sequences were detected by RT-PCR Using RT-PCR,
MNV sequences were detected consistently in the feces of only
twomice. Thus, a survey for MNV infection might require the use
of serologicalmethods, such as ELISA. The ﬁrst norovirus to infect
mice, MNV-1, caused death in severely immunocompromised
mice lacking recombination-activating gene 2 (RAG2) and
signal transducer and activator of transcription 1 (STAT-1;
RAG2/STAT1−/−) and mice lacking both the alpha/beta inter-
feron (IFN-α/β) and the IFN-γ receptors (IFN-αβγR−/−; Karst
et al., 2003;Mumphrey et al., 2007). In this study, themice infected
withMNV exhibited no clinical signs, though the testedmice, with
the exception of the mice from breeders, were genetically modi-
ﬁed, including compromised immune systems. Recently, MNVs
(exceptMNV-1) were associated with asymptomatic infection and
shedding in both normal and geneticallymodiﬁedmice (Hsu et al.,
2006; Muller et al., 2007). The origin of MNV in laboratorymouse
strains is unknown. Phylogenetic analysis of the partial capsid
sequences of MNV in this study showed that the isolated virus
strains comprised the reported MNV subgroups, though MNV-
1 and Ku29 isolated from the SPF facility were divergent form
the main group. However, bootstrap values for the position of
Ku29 were not high (<70%). Thus, further study is needed to
address whether the Ku29 isolate belongs to a newMNVgenotype.
These results indicate that attenuated (persistent) strains of MNV,
such as MNV-2, -3, and -4, are spread around the world, making
the viruses difﬁcult to detect in animals without active screening
(Muller et al., 2007; Barron et al., 2011). Using ELISA, we did not
detect MNV antibodies in stocked serum from mice transported
from domestic animal facilities before 2009 (data not shown).
These results suggest that MNV has been spreading through 50%
of animal facilities in Japan in only 2 years.
Finally, our results suggest that MNV infections have spread
widely throughout the animal facilities in Japan, not only con-
ventional mice colonies, but also SPF mice colonies. The ﬁndings
warrant further studies to elucidate the spread of MNV infec-
tion in SPF colonies, including breeders, in Japan. These results
also suggest that SPF laboratory mice, including commercial mice,
which might require considerable attention as an animal model
for human norovirus infection.
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